Interferon alfa therapy: toward an improved treatment for HIV infection.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Hyperbaric hyperoxia exposure in suppressing human immunodeficiency virus replication: An experimentalInfectious disease reports · 2020
   Article
2. COMPARATIVE ANALYSIS OF qPCR MEASUREMENT OF HIV VIRAL LOAD AND ELISA DETECTION OF p24 ANTIGEN AFTER HYPERBARIC OXYGEN EXPOSURE.African journal of infectious diseases · 2020
   Article
3. Naturally Occurring Fc-Dependent Antibody From HIV-Seronegative Individuals Promotes HIV-Induced IFN-α Production.Scientific reports · 2016
   Article
4. IFI44 suppresses HIV-1 LTR promoter activity and facilitates its latency.Virology · 2015
   Article
5. Immuno-modulatory strategies for reduction of HIV reservoir cells.Journal of theoretical biology · 2015
   Article
6. Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.Expert review of anti-infective therapy · 2014
   Review
7. CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals.PloS one · 2014
   Article
8. Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo.PloS one · 2014
   Article

Corrections and comments

• Comment on
  Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration.2013

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as